Bausch + Lomb advances two eye drop candidates to new trials

Go back to Bausch + Lomb advances two eye drop candidates to new trials
(NYSE: BLCO) Delayed: 17.73 --0 (-0%)
Previous Close $17.73    52 Week High
Open $17.73    52 Week Low
Day High $17.73    P/E N/A 
Day Low $17.73    EPS
Volume 601